The treatment was well tolerated. Most adverse events were mild and consisted primarily of irritation or erythema at the site of application.
Discovering Dermatology Times: September 2023 BCC Management Supplement
The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis
Incyte to Present Numerous Studies at EADV 2023
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Prolonged Remission in Rosacea: A Breakthrough With Subantibiotic Dose of Oral Doxycycline
Rocco Serrao, MD Looks Ahead to Bimekizumab’s Approval
2 Clarke Drive Cranbury, NJ 08512